Astrid S. Kahnt

Goethe University Frankfurt — Germany

Biochemistry, Genetics and Molecular Biology · Life Sciences

21h-index1.1kcitations57works11.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Eicosanoids and Hypertension Pharmacology(15), Acute Myeloid Leukemia Research(14), Histone Deacetylase Inhibitors Research(14), Peroxisome Proliferator-Activated Receptors(11), Inflammatory mediators and NSAID effects(9)

Publications57 total

Technical recommendations for analyzing oxylipins by liquid chromatography–mass spectrometry
Science Signaling·2025· 18 citedOpen Access
Identification of Natural Killer Cell Enhancers Through Mimicking of the Tumor Microenvironment
Chemistry - A European Journal·2025Open Access
Identification of small molecule enhancers of NK cell tumoricidal activity via a tumor microenvironment-mimicking co-culture assay
2024
The role of human 5-Lipoxygenase (5-LO) in carcinogenesis - a question of canonical and non-canonical functions
Oncogene·2024· 29 citedOpen Access
Supplementary Figure Legends from 5-Lipoxygenase Is a Candidate Target for Therapeutic Management of Stem Cell–like Cells in Acute Myeloid Leukemia
2023Open Access
Supplementary Figure S3 from 5-Lipoxygenase Is a Candidate Target for Therapeutic Management of Stem Cell–like Cells in Acute Myeloid Leukemia
2023Open Access
Data from 5-Lipoxygenase Is a Candidate Target for Therapeutic Management of Stem Cell–like Cells in Acute Myeloid Leukemia
2023Open Access
Supplementary Figure S2 from 5-Lipoxygenase Is a Candidate Target for Therapeutic Management of Stem Cell–like Cells in Acute Myeloid Leukemia
2023Open Access
Supplementary Figure S5 from 5-Lipoxygenase Is a Candidate Target for Therapeutic Management of Stem Cell–like Cells in Acute Myeloid Leukemia
2023Open Access
Supplementary Figure S1 from 5-Lipoxygenase Is a Candidate Target for Therapeutic Management of Stem Cell–like Cells in Acute Myeloid Leukemia
2023Open Access
Data from 5-Lipoxygenase Is a Candidate Target for Therapeutic Management of Stem Cell–like Cells in Acute Myeloid Leukemia
2023Open Access
Supplementary Figure S1 from 5-Lipoxygenase Is a Candidate Target for Therapeutic Management of Stem Cell–like Cells in Acute Myeloid Leukemia
2023Open Access
Supplementary Figure S7 from 5-Lipoxygenase Is a Candidate Target for Therapeutic Management of Stem Cell–like Cells in Acute Myeloid Leukemia
2023Open Access
Supplementary Figure Legends from 5-Lipoxygenase Is a Candidate Target for Therapeutic Management of Stem Cell–like Cells in Acute Myeloid Leukemia
2023Open Access
Supplementary Figure S6 from 5-Lipoxygenase Is a Candidate Target for Therapeutic Management of Stem Cell–like Cells in Acute Myeloid Leukemia
2023Open Access
Supplementary Figure S7 from 5-Lipoxygenase Is a Candidate Target for Therapeutic Management of Stem Cell–like Cells in Acute Myeloid Leukemia
2023Open Access
Supplementary Figure S4 from 5-Lipoxygenase Is a Candidate Target for Therapeutic Management of Stem Cell–like Cells in Acute Myeloid Leukemia
2023Open Access
Supplementary Figure S2 from 5-Lipoxygenase Is a Candidate Target for Therapeutic Management of Stem Cell–like Cells in Acute Myeloid Leukemia
2023Open Access
Supplementary Figure S6 from 5-Lipoxygenase Is a Candidate Target for Therapeutic Management of Stem Cell–like Cells in Acute Myeloid Leukemia
2023Open Access
Supplementary Figure S4 from 5-Lipoxygenase Is a Candidate Target for Therapeutic Management of Stem Cell–like Cells in Acute Myeloid Leukemia
2023Open Access
page 1 of 3Next →

Frequent Co-authors

Dieter Steinhilber(41), Ewgenij Proschak(25), Jessica Roos(16), Ricardo Capelo(16), Estel la Buscató(15), Ingrid Fleming(14), Thorsten J. Maier(14), Martin Ruthardt(14), Claudia Oancea(13), Maria Heinßmann(13), Hannelore Held(13), Elena Puccetti(13), Carlo Angioni(11), Dilawar Khan(11), Gerd Geißlinger(10), Daniel Merk(9), Jan Heering(7), Tamara Göbel(7), Manfred Schubert‐Zsilavecz(7), Sandra K. Wittmann(6)